293 related articles for article (PubMed ID: 10597865)
1. Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans?
Cavero I; Mestre M; Guillon JM; Heuillet E; Roach AG
Drug Saf; 1999; 21 Suppl 1():19-31; discussion 81-7. PubMed ID: 10597865
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
3. [The effect of second generation histamine antagonists on the heart].
Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
[TBL] [Abstract][Full Text] [Related]
4. Second-generation antihistamines: the risk of ventricular arrhythmias.
DuBuske LM
Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
Delgado LF; Pferferman A; Solé D; Naspitz CK
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
Hey JA; del Prado M; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity of new antihistamines and cisapride.
Paakkari I
Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic overview of oral second-generation H1 antihistamines.
González MA; Estes KS
Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
[TBL] [Abstract][Full Text] [Related]
9. Cardiac actions of antihistamines.
Woosley RL
Annu Rev Pharmacol Toxicol; 1996; 36():233-52. PubMed ID: 8725389
[TBL] [Abstract][Full Text] [Related]
10. Predictors of torsades de pointes in rabbit ventricles perfused with sedating and nonsedating histamine H1-receptor antagonists.
Gilbert JD; Cahill SA; McCartney DG; Lukas A; Gross GJ
Can J Physiol Pharmacol; 2000 May; 78(5):407-14. PubMed ID: 10841436
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity of histamine and the possible role of histamine in the arrhythmogenesis produced by certain antihistamines.
Llenas J; Cardelús I; Heredia A; de Mora F; Gristwood RW
Drug Saf; 1999; 21 Suppl 1():33-8; discussion 81-7. PubMed ID: 10597866
[TBL] [Abstract][Full Text] [Related]
12. Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine.
Salata JJ; Jurkiewicz NK; Wallace AA; Stupienski RF; Guinosso PJ; Lynch JJ
Circ Res; 1995 Jan; 76(1):110-9. PubMed ID: 8001268
[TBL] [Abstract][Full Text] [Related]
13. Safety of antihistamines in children.
Ten Eick AP; Blumer JL; Reed MD
Drug Saf; 2001; 24(2):119-47. PubMed ID: 11235817
[TBL] [Abstract][Full Text] [Related]
14. Potential cardiac toxicity of H1-antihistamines.
Yap YG; Camm AJ
Clin Allergy Immunol; 2002; 17():389-419. PubMed ID: 12113224
[TBL] [Abstract][Full Text] [Related]
15. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.
De Ponti F; Poluzzi E; Cavalli A; Recanatini M; Montanaro N
Drug Saf; 2002; 25(4):263-86. PubMed ID: 11994029
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular toxicity of antihistamines.
Smith SJ
Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 2):348-54. PubMed ID: 7916150
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular safety of second-generation antihistamines.
Barbey JT; Anderson M; Ciprandi G; Frew AJ; Morad M; Priori SG; Ongini E; Affrime MB
Am J Rhinol; 1999; 13(3):235-43. PubMed ID: 10392245
[TBL] [Abstract][Full Text] [Related]
18. Regulation of potassium channels by nonsedating antihistamines.
Berul CI; Morad M
Circulation; 1995 Apr; 91(8):2220-5. PubMed ID: 7697852
[TBL] [Abstract][Full Text] [Related]
19. Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions.
Crumb WJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):261-4. PubMed ID: 10604956
[TBL] [Abstract][Full Text] [Related]
20. Blockade of cardiac potassium and other channels by antihistamines.
Delpón E; Valenzuela C; Tamargo J
Drug Saf; 1999; 21 Suppl 1():11-8; discussion 81-7. PubMed ID: 10597864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
